Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project

The aim of this study was to investigate the frequency, possible predictive factors, and prognosis of deteriorating ischemic stroke in 4 clinical categories according to the classification of the Oxfordshire Community Stroke Project (OCSP). A total of 350 patients with first-ever ischemic stroke who...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Stroke (1970) 2000-09, Vol.31 (9), p.2049-2054
Hauptverfasser: TEI, Hideaki, UCHIYAMA, Shinichiro, OHARA, Kuniko, KOBAYASHI, Michiko, UCHIYAMA, Yumiko, FUKUZAWA, Megumi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2054
container_issue 9
container_start_page 2049
container_title Stroke (1970)
container_volume 31
creator TEI, Hideaki
UCHIYAMA, Shinichiro
OHARA, Kuniko
KOBAYASHI, Michiko
UCHIYAMA, Yumiko
FUKUZAWA, Megumi
description The aim of this study was to investigate the frequency, possible predictive factors, and prognosis of deteriorating ischemic stroke in 4 clinical categories according to the classification of the Oxfordshire Community Stroke Project (OCSP). A total of 350 patients with first-ever ischemic stroke who presented within 24 hours of onset were enrolled. Based on the OCSP criteria, cerebral infarctions were divided into the following 4 clinical categories: total anterior circulation infarcts (TACI), partial anterior circulation infarcts (PACI), lacunar infarcts (LACI), and posterior circulation infarcts (POCI). Clinical deterioration was defined as a decrease of >/=1 points in the Canadian Neurological Scale (CNS) (in TACI, PACI, and LACI) or Rankin Scale (RS) (in POCI) during 7 days from the onset. In each clinical category, deteriorating (D) and nondeteriorating (ND) patients were compared in terms of their background characteristics, risk factors, vital signs, laboratory data, and cranial CT at the time of hospitalization. The acute-phase mortality and functional outcome were also compared. The subjects comprised 86 patients (24.6%) with TACI, 63 (18.0%) with PACI, 141 (40.3%) with LACI, and 60 (17.1%) with POCI. Overall, 90 patients (25.7%) deteriorated. The frequency was very high in TACI (41.9%), followed by LACI (26.2%) and POCI (21.7%), whereas it was very low in PACI (6. 3%). There were some clinical variables that differed significantly between D and ND groups. In the patients with TACI, early abnormalities of the cranial CT and significant stenoses in corresponding arteries were more frequent in the D than the ND group. In those with LACI, the CNS and hematocrit were lower in the D than the ND group. In those with POCI, cerebral atrophy was more severe and significant stenoses in vertebrobasilar arteries were more frequent in the D than ND group. The mortality of the D groups of patients with TACI and POCI exceeded 35%, and the functional outcome was worse in the D group than in the ND group of patients with TACI, LACI, and POCI. The frequency of deterioration in acute ischemic stroke significantly differed among the OCSP subgroups, and deterioration worsened the prognosis. There were some factors that could predict deterioration: early CT findings in TACI, large-artery atherosclerosis in TACI and POCI, and stroke severity in LACI. Further research to find sophisticated radiological and chemical markers appears to be needed.
doi_str_mv 10.1161/01.str.31.9.2049
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_72244421</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>60615825</sourcerecordid><originalsourceid>FETCH-LOGICAL-c542t-d625473a53dc3380a6a3a1d7d43ac8ed8b403c2615ebb2372b3bde0678e04df93</originalsourceid><addsrcrecordid>eNpdkc1r3DAQxUVpabZp7z0VUUpvdkYftuVj2X5CICVJz0KWxlltbSuVZMj-91XYhZacBobfe8y8R8hbBjVjLbsAVqcca8HqvuYg-2dkwxouK9ly9ZxsAERfcdn3Z-RVSnsA4EI1L8kZg75TwNWGzJ8xY_QhmuyXO-qT3eHsLS224TdSv1BJ7eQXb81Ercl4F6LHVHYmJT96dHQ40LxDevUwhujSzkek2zDP6-Lzgd4cfX7GsEebX5MXo5kSvjnNc_Lr65fb7ffq8urbj-2ny8o2kufKtbyRnTCNcFYIBaY1wjDXOSmMVejUIEFY3rIGh4GLjg9icAhtpxCkG3txTj4efe9j-LNiynoun-E0mQXDmnTHuZSSswK-fwLuwxqXcptmfdepFoQqEBwhG0NKEUd9H_1s4kEz0I89aGD65vZaC6Z7_dhDkbw7-a7DjO4_wTH4Anw4ASaVaMdoFuvTP04q1RTsL_gskYI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>197786038</pqid></control><display><type>article</type><title>Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><source>Journals@Ovid Complete</source><creator>TEI, Hideaki ; UCHIYAMA, Shinichiro ; OHARA, Kuniko ; KOBAYASHI, Michiko ; UCHIYAMA, Yumiko ; FUKUZAWA, Megumi</creator><creatorcontrib>TEI, Hideaki ; UCHIYAMA, Shinichiro ; OHARA, Kuniko ; KOBAYASHI, Michiko ; UCHIYAMA, Yumiko ; FUKUZAWA, Megumi</creatorcontrib><description>The aim of this study was to investigate the frequency, possible predictive factors, and prognosis of deteriorating ischemic stroke in 4 clinical categories according to the classification of the Oxfordshire Community Stroke Project (OCSP). A total of 350 patients with first-ever ischemic stroke who presented within 24 hours of onset were enrolled. Based on the OCSP criteria, cerebral infarctions were divided into the following 4 clinical categories: total anterior circulation infarcts (TACI), partial anterior circulation infarcts (PACI), lacunar infarcts (LACI), and posterior circulation infarcts (POCI). Clinical deterioration was defined as a decrease of &gt;/=1 points in the Canadian Neurological Scale (CNS) (in TACI, PACI, and LACI) or Rankin Scale (RS) (in POCI) during 7 days from the onset. In each clinical category, deteriorating (D) and nondeteriorating (ND) patients were compared in terms of their background characteristics, risk factors, vital signs, laboratory data, and cranial CT at the time of hospitalization. The acute-phase mortality and functional outcome were also compared. The subjects comprised 86 patients (24.6%) with TACI, 63 (18.0%) with PACI, 141 (40.3%) with LACI, and 60 (17.1%) with POCI. Overall, 90 patients (25.7%) deteriorated. The frequency was very high in TACI (41.9%), followed by LACI (26.2%) and POCI (21.7%), whereas it was very low in PACI (6. 3%). There were some clinical variables that differed significantly between D and ND groups. In the patients with TACI, early abnormalities of the cranial CT and significant stenoses in corresponding arteries were more frequent in the D than the ND group. In those with LACI, the CNS and hematocrit were lower in the D than the ND group. In those with POCI, cerebral atrophy was more severe and significant stenoses in vertebrobasilar arteries were more frequent in the D than ND group. The mortality of the D groups of patients with TACI and POCI exceeded 35%, and the functional outcome was worse in the D group than in the ND group of patients with TACI, LACI, and POCI. The frequency of deterioration in acute ischemic stroke significantly differed among the OCSP subgroups, and deterioration worsened the prognosis. There were some factors that could predict deterioration: early CT findings in TACI, large-artery atherosclerosis in TACI and POCI, and stroke severity in LACI. Further research to find sophisticated radiological and chemical markers appears to be needed.</description><identifier>ISSN: 0039-2499</identifier><identifier>EISSN: 1524-4628</identifier><identifier>DOI: 10.1161/01.str.31.9.2049</identifier><identifier>PMID: 10978028</identifier><identifier>CODEN: SJCCA7</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Acute Disease ; Adult ; Aged ; Aged, 80 and over ; Anticoagulants - therapeutic use ; Biological and medical sciences ; Blood Chemical Analysis ; Brain Infarction - classification ; Brain Infarction - diagnostic imaging ; Brain Infarction - physiopathology ; Cerebral Angiography ; Electrocardiography ; Female ; Fibrinolytic Agents - therapeutic use ; Humans ; Male ; Medical sciences ; Middle Aged ; Mortality ; Neurology ; Platelet Aggregation Inhibitors - therapeutic use ; Prognosis ; Stroke - classification ; Stroke - drug therapy ; Stroke - physiopathology ; Tomography, X-Ray Computed ; Vascular diseases and vascular malformations of the nervous system</subject><ispartof>Stroke (1970), 2000-09, Vol.31 (9), p.2049-2054</ispartof><rights>2000 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Sep 2000</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c542t-d625473a53dc3380a6a3a1d7d43ac8ed8b403c2615ebb2372b3bde0678e04df93</citedby><cites>FETCH-LOGICAL-c542t-d625473a53dc3380a6a3a1d7d43ac8ed8b403c2615ebb2372b3bde0678e04df93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1488528$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10978028$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>TEI, Hideaki</creatorcontrib><creatorcontrib>UCHIYAMA, Shinichiro</creatorcontrib><creatorcontrib>OHARA, Kuniko</creatorcontrib><creatorcontrib>KOBAYASHI, Michiko</creatorcontrib><creatorcontrib>UCHIYAMA, Yumiko</creatorcontrib><creatorcontrib>FUKUZAWA, Megumi</creatorcontrib><title>Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project</title><title>Stroke (1970)</title><addtitle>Stroke</addtitle><description>The aim of this study was to investigate the frequency, possible predictive factors, and prognosis of deteriorating ischemic stroke in 4 clinical categories according to the classification of the Oxfordshire Community Stroke Project (OCSP). A total of 350 patients with first-ever ischemic stroke who presented within 24 hours of onset were enrolled. Based on the OCSP criteria, cerebral infarctions were divided into the following 4 clinical categories: total anterior circulation infarcts (TACI), partial anterior circulation infarcts (PACI), lacunar infarcts (LACI), and posterior circulation infarcts (POCI). Clinical deterioration was defined as a decrease of &gt;/=1 points in the Canadian Neurological Scale (CNS) (in TACI, PACI, and LACI) or Rankin Scale (RS) (in POCI) during 7 days from the onset. In each clinical category, deteriorating (D) and nondeteriorating (ND) patients were compared in terms of their background characteristics, risk factors, vital signs, laboratory data, and cranial CT at the time of hospitalization. The acute-phase mortality and functional outcome were also compared. The subjects comprised 86 patients (24.6%) with TACI, 63 (18.0%) with PACI, 141 (40.3%) with LACI, and 60 (17.1%) with POCI. Overall, 90 patients (25.7%) deteriorated. The frequency was very high in TACI (41.9%), followed by LACI (26.2%) and POCI (21.7%), whereas it was very low in PACI (6. 3%). There were some clinical variables that differed significantly between D and ND groups. In the patients with TACI, early abnormalities of the cranial CT and significant stenoses in corresponding arteries were more frequent in the D than the ND group. In those with LACI, the CNS and hematocrit were lower in the D than the ND group. In those with POCI, cerebral atrophy was more severe and significant stenoses in vertebrobasilar arteries were more frequent in the D than ND group. The mortality of the D groups of patients with TACI and POCI exceeded 35%, and the functional outcome was worse in the D group than in the ND group of patients with TACI, LACI, and POCI. The frequency of deterioration in acute ischemic stroke significantly differed among the OCSP subgroups, and deterioration worsened the prognosis. There were some factors that could predict deterioration: early CT findings in TACI, large-artery atherosclerosis in TACI and POCI, and stroke severity in LACI. Further research to find sophisticated radiological and chemical markers appears to be needed.</description><subject>Acute Disease</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anticoagulants - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blood Chemical Analysis</subject><subject>Brain Infarction - classification</subject><subject>Brain Infarction - diagnostic imaging</subject><subject>Brain Infarction - physiopathology</subject><subject>Cerebral Angiography</subject><subject>Electrocardiography</subject><subject>Female</subject><subject>Fibrinolytic Agents - therapeutic use</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Neurology</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Prognosis</subject><subject>Stroke - classification</subject><subject>Stroke - drug therapy</subject><subject>Stroke - physiopathology</subject><subject>Tomography, X-Ray Computed</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><issn>0039-2499</issn><issn>1524-4628</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc1r3DAQxUVpabZp7z0VUUpvdkYftuVj2X5CICVJz0KWxlltbSuVZMj-91XYhZacBobfe8y8R8hbBjVjLbsAVqcca8HqvuYg-2dkwxouK9ly9ZxsAERfcdn3Z-RVSnsA4EI1L8kZg75TwNWGzJ8xY_QhmuyXO-qT3eHsLS224TdSv1BJ7eQXb81Ercl4F6LHVHYmJT96dHQ40LxDevUwhujSzkek2zDP6-Lzgd4cfX7GsEebX5MXo5kSvjnNc_Lr65fb7ffq8urbj-2ny8o2kufKtbyRnTCNcFYIBaY1wjDXOSmMVejUIEFY3rIGh4GLjg9icAhtpxCkG3txTj4efe9j-LNiynoun-E0mQXDmnTHuZSSswK-fwLuwxqXcptmfdepFoQqEBwhG0NKEUd9H_1s4kEz0I89aGD65vZaC6Z7_dhDkbw7-a7DjO4_wTH4Anw4ASaVaMdoFuvTP04q1RTsL_gskYI</recordid><startdate>20000901</startdate><enddate>20000901</enddate><creator>TEI, Hideaki</creator><creator>UCHIYAMA, Shinichiro</creator><creator>OHARA, Kuniko</creator><creator>KOBAYASHI, Michiko</creator><creator>UCHIYAMA, Yumiko</creator><creator>FUKUZAWA, Megumi</creator><general>Lippincott Williams &amp; Wilkins</general><general>American Heart Association, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20000901</creationdate><title>Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project</title><author>TEI, Hideaki ; UCHIYAMA, Shinichiro ; OHARA, Kuniko ; KOBAYASHI, Michiko ; UCHIYAMA, Yumiko ; FUKUZAWA, Megumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c542t-d625473a53dc3380a6a3a1d7d43ac8ed8b403c2615ebb2372b3bde0678e04df93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Acute Disease</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anticoagulants - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blood Chemical Analysis</topic><topic>Brain Infarction - classification</topic><topic>Brain Infarction - diagnostic imaging</topic><topic>Brain Infarction - physiopathology</topic><topic>Cerebral Angiography</topic><topic>Electrocardiography</topic><topic>Female</topic><topic>Fibrinolytic Agents - therapeutic use</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Neurology</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Prognosis</topic><topic>Stroke - classification</topic><topic>Stroke - drug therapy</topic><topic>Stroke - physiopathology</topic><topic>Tomography, X-Ray Computed</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>TEI, Hideaki</creatorcontrib><creatorcontrib>UCHIYAMA, Shinichiro</creatorcontrib><creatorcontrib>OHARA, Kuniko</creatorcontrib><creatorcontrib>KOBAYASHI, Michiko</creatorcontrib><creatorcontrib>UCHIYAMA, Yumiko</creatorcontrib><creatorcontrib>FUKUZAWA, Megumi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Stroke (1970)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>TEI, Hideaki</au><au>UCHIYAMA, Shinichiro</au><au>OHARA, Kuniko</au><au>KOBAYASHI, Michiko</au><au>UCHIYAMA, Yumiko</au><au>FUKUZAWA, Megumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project</atitle><jtitle>Stroke (1970)</jtitle><addtitle>Stroke</addtitle><date>2000-09-01</date><risdate>2000</risdate><volume>31</volume><issue>9</issue><spage>2049</spage><epage>2054</epage><pages>2049-2054</pages><issn>0039-2499</issn><eissn>1524-4628</eissn><coden>SJCCA7</coden><abstract>The aim of this study was to investigate the frequency, possible predictive factors, and prognosis of deteriorating ischemic stroke in 4 clinical categories according to the classification of the Oxfordshire Community Stroke Project (OCSP). A total of 350 patients with first-ever ischemic stroke who presented within 24 hours of onset were enrolled. Based on the OCSP criteria, cerebral infarctions were divided into the following 4 clinical categories: total anterior circulation infarcts (TACI), partial anterior circulation infarcts (PACI), lacunar infarcts (LACI), and posterior circulation infarcts (POCI). Clinical deterioration was defined as a decrease of &gt;/=1 points in the Canadian Neurological Scale (CNS) (in TACI, PACI, and LACI) or Rankin Scale (RS) (in POCI) during 7 days from the onset. In each clinical category, deteriorating (D) and nondeteriorating (ND) patients were compared in terms of their background characteristics, risk factors, vital signs, laboratory data, and cranial CT at the time of hospitalization. The acute-phase mortality and functional outcome were also compared. The subjects comprised 86 patients (24.6%) with TACI, 63 (18.0%) with PACI, 141 (40.3%) with LACI, and 60 (17.1%) with POCI. Overall, 90 patients (25.7%) deteriorated. The frequency was very high in TACI (41.9%), followed by LACI (26.2%) and POCI (21.7%), whereas it was very low in PACI (6. 3%). There were some clinical variables that differed significantly between D and ND groups. In the patients with TACI, early abnormalities of the cranial CT and significant stenoses in corresponding arteries were more frequent in the D than the ND group. In those with LACI, the CNS and hematocrit were lower in the D than the ND group. In those with POCI, cerebral atrophy was more severe and significant stenoses in vertebrobasilar arteries were more frequent in the D than ND group. The mortality of the D groups of patients with TACI and POCI exceeded 35%, and the functional outcome was worse in the D group than in the ND group of patients with TACI, LACI, and POCI. The frequency of deterioration in acute ischemic stroke significantly differed among the OCSP subgroups, and deterioration worsened the prognosis. There were some factors that could predict deterioration: early CT findings in TACI, large-artery atherosclerosis in TACI and POCI, and stroke severity in LACI. Further research to find sophisticated radiological and chemical markers appears to be needed.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>10978028</pmid><doi>10.1161/01.str.31.9.2049</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0039-2499
ispartof Stroke (1970), 2000-09, Vol.31 (9), p.2049-2054
issn 0039-2499
1524-4628
language eng
recordid cdi_proquest_miscellaneous_72244421
source MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection; Journals@Ovid Complete
subjects Acute Disease
Adult
Aged
Aged, 80 and over
Anticoagulants - therapeutic use
Biological and medical sciences
Blood Chemical Analysis
Brain Infarction - classification
Brain Infarction - diagnostic imaging
Brain Infarction - physiopathology
Cerebral Angiography
Electrocardiography
Female
Fibrinolytic Agents - therapeutic use
Humans
Male
Medical sciences
Middle Aged
Mortality
Neurology
Platelet Aggregation Inhibitors - therapeutic use
Prognosis
Stroke - classification
Stroke - drug therapy
Stroke - physiopathology
Tomography, X-Ray Computed
Vascular diseases and vascular malformations of the nervous system
title Deteriorating ischemic stroke in 4 clinical categories classified by the Oxfordshire Community Stroke Project
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T12%3A36%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Deteriorating%20ischemic%20stroke%20in%204%20clinical%20categories%20classified%20by%20the%20Oxfordshire%20Community%20Stroke%20Project&rft.jtitle=Stroke%20(1970)&rft.au=TEI,%20Hideaki&rft.date=2000-09-01&rft.volume=31&rft.issue=9&rft.spage=2049&rft.epage=2054&rft.pages=2049-2054&rft.issn=0039-2499&rft.eissn=1524-4628&rft.coden=SJCCA7&rft_id=info:doi/10.1161/01.str.31.9.2049&rft_dat=%3Cproquest_cross%3E60615825%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=197786038&rft_id=info:pmid/10978028&rfr_iscdi=true